Research ArticleArticle
Assessment of Vandetanib as an Inhibitor of Various Human Renal Transporters: Inhibition of Multidrug and Toxin Extrusion as a Possible Mechanism Leading to Decreased Cisplatin and Creatinine Clearance
Hong Shen, Zheng Yang, Weiping Zhao, Yueping Zhang and A. David Rodrigues
Drug Metabolism and Disposition December 2013, 41 (12) 2095-2103; DOI: https://doi.org/10.1124/dmd.113.053215
Hong Shen
Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, Princeton, New Jersey
Zheng Yang
Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, Princeton, New Jersey
Weiping Zhao
Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, Princeton, New Jersey
Yueping Zhang
Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, Princeton, New Jersey
A. David Rodrigues
Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, Princeton, New Jersey

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Inhibition of MATE1 and MATE2K by Vandetanib
Hong Shen, Zheng Yang, Weiping Zhao, Yueping Zhang and A. David Rodrigues
Drug Metabolism and Disposition December 1, 2013, 41 (12) 2095-2103; DOI: https://doi.org/10.1124/dmd.113.053215
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement